Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision medicine for rare diseases: The times they are A-Changin'
Margarida D. Amaral
Current Opinion in Pharmacology (2022) Vol. 63, pp. 102201-102201
Closed Access | Times Cited: 11

Showing 11 citing articles:

Access to gene therapy for rare diseases when commercialization is not fit for purpose
Thomas A. Fox, Juan A. Bueren, Fabio Candotti, et al.
Nature Medicine (2023) Vol. 29, Iss. 3, pp. 518-519
Closed Access | Times Cited: 36
Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics
Emmanuelle Cacoub, Nathalie Barreto Lefebvre, Dimitrije Milunov, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
L1077P CFTR pathogenic variant function rescue by Elexacaftor–Tezacaftor–Ivacaftor in cystic fibrosis patient-derived air–liquid interface (ALI) cultures and organoids: in vitro guided personalized therapy of non-F508del patients
Stefania Lo Cicero, Germana Castelli, Giovanna Blaconà, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 9
Advancing Precision Medicine in South Tyrol, Italy: A Public Health Development Proposal for a Bilingual, Autonomous Province
Christian J. Wiedermann
Journal of Personalized Medicine (2023) Vol. 13, Iss. 6, pp. 972-972
Open Access | Times Cited: 5
RDKG-115: Assisting drug repurposing and discovery for rare diseases by trimodal knowledge graph embedding
Chaoyu Zhu, Xiaoqiong Xia, Nan Li, et al.
Computers in Biology and Medicine (2023) Vol. 164, pp. 107262-107262
Open Access | Times Cited: 5
A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia
Renate Kos, Myrofora Goutaki, Helene Kobbernagel, et al.
ERJ Open Research (2023) Vol. 10, Iss. 1, pp. 00115-2023
Open Access | Times Cited: 4
The Role of Patient Organizations in Shaping Research, Health Policies, and Health Services for Rare Genetic Diseases: The Dutch Experience
Ysbrand Poortman, Martina H. Ens‐Dokkum, Irmgard Nippert
Genes (2024) Vol. 15, Iss. 9, pp. 1162-1162
Open Access
Rare diseases: What rheumatologists need to know?
Renan Rodrigues Neves Ribeiro do Nascimento, Daniela Gerent Petry Piotto, Eutília Andrade Medeiros Freire, et al.
Advances in Rheumatology (2024) Vol. 64, Iss. 1
Open Access
Genetic Testing for Rare Diseases
José M. Millán, Gema García‐García
Diagnostics (2022) Vol. 12, Iss. 4, pp. 809-809
Open Access | Times Cited: 2
Genetic Testing for Rare Diseases
José M. Millán
MDPI eBooks (2022)
Open Access
Editorial overview – 2022 respiratory issue: Cystic fibrosis pathophysiology, models, and novel therapies
Carla M. P. Ribeiro, Martina Gentzsch
Current Opinion in Pharmacology (2022) Vol. 67, pp. 102289-102289
Closed Access
Page 1

Scroll to top